Earnings Feed
Start Free
$USRM·4

U.S. Stem Cell, Inc. · Sep 23, 4:06 PM ET

U.S. Stem Cell, Inc. 4

4 · U.S. Stem Cell, Inc. · Filed Sep 23, 2016

Insider Transaction Report

Form 4
Period: 2016-09-19
U.S. Stem Cell, Inc.BHRT.OB
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2016-09-19+10,000,000→ 10,341,284 total
    Exercise: $0.02Exp: 2026-09-19→ Common Stock (10,000,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-09-19+1,500,000→ 11,841,284 total
    Exercise: $0.02From: 2016-09-19Exp: 2026-09-19→ Common Stock (1,500,000 underlying)
Holdings

  • Common Stock

    9,793
Footnotes (1)
  • [F1]2,500,000 vest on 09/17/2017, 2,500,000 vest on 09/17/2018, 2,500,000 vest on 09/17/2019, and 2,500,000 vest on 09/17/2020.

Documents

1 file
  • 4
    form4-tomas092216.xmlPrimary

    OWNERSHIP DOCUMENT